Orriciat Recorp FD-302 (Rev. 5-8-10) FEDERAL BUREAU OF INVESTIGATION Date of entry On August 21, 2019 at approximately 0845 hours the undersigned, along with Special Agent PF of the Office of the Inspector General, Special Agent PY of the Federal Bureau of Investigation and stant ted States Attorneys for the Southern District of New York — -— lm did interview Federal Bureau of Prisons sychiatrist Doctor ro date of birth a. at the Southern District of NY Dr. i informed that she has been with the BOP since 07/17/2000 and that she has been the staff psychiatrist since 2002. Dr. i advised as to the procedures and policies in place at the MCC for her role and how inmates meet with the psychiatrists. Dr. | | informed that she met with EPSTEIN on EPSTEIN had no clear recollection of the incident. EPSTEIN went on to even tell | that he is “too mu “doesn’t like pain” and that suicide goes against his Jew according to i. EPS psych unit and even those guards that were assigned to observe him. | | of a coward” to commit suicide, that he religion. Also ,IN had many normal interactions with those in the did advise the staff that EPSTEIN would need a cellmate. When the ps staff reviewed EPSTEIN’s file in their routine meetings EPSTEIN yielded no factors that would have placed him back in suicide watch. Dr. || stated that had she or her department been notified that EPSTEIN changed his will that that would have been a factor that would have warranted a review of his mental state and would have probably been placed back in suicide watch. The interview concluded at 0930 hours. Further details of the interview and statements made by Dr. | are recorded on the interview notes which are attached to this report. Investigationon 08 / York, New Y nited State File# 9OA-NY-3151227 Date drafted me __ This document contains neither recommendations nor conclusions of the FBI. It is the property of the FBI and is loaned to your agency; it and its contents are not to be distributed outside your agency. EFTA00059383

--=PAGE_BREAK=--

FD-302a (Rev. 5-8-10) 9O0A-NY-3151227 Continuation of FD-302 of (U) Interview of Dr. | ,On 08/21/2019 page 2 Of 2 EFTA00059384